Stenosed segments of arteries significantly alter the blood flow known from healthy vessels. In particular, the wall shear stress at critically stenosed arteries is at least an order of magnitude higher than in healthy situations. This alteration represents a change in physical force and might be used as a trigger signal for drug delivery. Mechanosensitive drug delivery systems, that preferentially release their payload under increased shear stress, are discussed. Therefore, besides biological or chemical markers, physical triggers are a further principle approach for targeted drug delivery. We hypothesize that such physical trigger is much more powerful to release drugs for vasodilation, plaque stabilization or clot lysis at stenosed arteries than any known biological or chemical ones.
vessels, where physiological structures are broken down by atherosclerosis.
An approach to apply mechanical forces and their influence on atherosclerosis physiopathology has to target the modified hemodynamic conditions and flow variations specific for cardiovascular diseases. The influence of mechanical conditions on vascular disease was discussed. For example, Caro 13 reviewed the available approaches exposing more than a century of debates. He has concluded that wall shear stress contributes mechanically to the development of atherosclerosis, especially in low shear range regions.
This discovery might contribute to further understand a complex cascade of biomechanical physiopathology of atherosclerosis. For a given flow, the wall shear stress is inversely proportional to the vessel diameter. 14 Unhealthy low shear stress seems to influence the balance between pro-atherogenic and anti-atherogenic transcription factors and thus, acts pro-atherogenically. 15 Once plaque develops, it alters the local hemodynamic flow condition and the shear stress around the vessel stenosis significantly increases. In a lumen obstruction with 60% of the original diameter, the shear stress is four times higher than in the normal vascular system. 16 In a 80% stenosis, it becomes more than ten times higher. 16 At arterial bifurcation and aortic valves, a less prominent increase in wall shear stress is measured. 17 The actual pathophysiological understanding of shear stress variation in arteries were recently reviewed by Wentzel et al.
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Sections:
Wall shear stress: Mechanisms for targeted drug delivery
Blood is regarded as a viscous fluid that moves along the vessel wall (often considered as a solid boundary) and incurs a shear stress on that wall. Under laminar flow conditions, which is usually a reasonable assumption and results in a parabolic blood velocity profile (see figure 1) , the shear stress τ is expressed by where η is the viscosity, Q the flow rate and r denotes the vessel radius. 19 An even more detailed description is presented by E. Wellnhofer et al.
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The blood flow through a healthy artery generates a shear stress of about 1 Pa. As the conservation of mass is valid within the blood vessel system, constrictions (of the integrated cross-section) result in an increased velocity associated with higher shear stress (figure 1). Therefore, one observes shear stresses that are an order of magnitude higher in stenosed vessels compared to healthy ones. A heart bypass can reduce the shear stress. This physical phenomenon can be used to preferentially release drugs at stenosis taking advantage of shear-stress-sensitive containers of sub-micrometer size.
Morphology of atherosclerosis
The anatomy of atherosclerotic plaques is well known and categorized into six classes of severity, as defined by histological analysis. found in vivo could, therefore, be even higher than predicted using the simplified models.
As to the morphology of the atherosclerosis, it should be mentioned, that the role of shear stress in its pathogenesis is well known, see e.g. 19 The wall shear stress acts on the endothelial lining of the vasculature, which responds as a mechanotransducerinduces the release of various substances including the vasodilator nitric oxide. The formation of the stenosis is, therefore, not easy to understand, although many phenomena are known in detail.
Mechanosensitive drug containers for targeted drug delivery
To take advantage of these atherosclerosis-specific blood flow variations, two approaches are currently presented: the use of mechano-sensitive liposomes 1 and shear stresssensitive nanoparticle aggregates.
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The first approach consists of an active compound encapsulated in shear stress sensitive liposomes 1 (figure 2) that release their payload at enhanced forces present near stenosis.
The main clinical aim is a prompt treatment after a myocardial infarction or stroke. It is clear that only limited data are available at this point in time and that many challenges lie ahead until shear stress targeting will be available as a powerful clinical tool.
We have to state, however, that the aggregate particle approach is somehow worrisome.
These particles might be collected in the lungs, but definitely be dispersed as they pass through the spleen, assuming they are not scavenged in an accelerated manner. It is clear that only limited data are available at this point in time and that many challenges lie ahead until shear stress targeting will be available as a powerful clinical tool, especially if one follows the approach of Korin et al.
Artificial mechanosensitive liposomes
The phospholipid is a remarkable molecular arrangement frequently found in nature. It contains a hydrophilic, i.e. water-attracting, head and a hydrophobic, i.e. water-repelling, tail. At concentrations lower than 10 -12 M phospholipids associate into superstructures to minimize contact between bulk water and the hydrophobic parts of the molecules. Bernard et al. 39 discussed the shear-induced permeation and fusion of lipid vesicles via a shear-induced, metastable, lentil-shaped state. They combined cylindrically shaped lipids, which favor planar membranes, and surfactants with conical shape, which tolerate rather high curvatures. 33 In equilibrium the surfactants are homogeneously distributed in the vesicle. The application of shear stress induces surfactant clustering and changes the morphology from spherical to lentil shape. At the cluster sites along the equator pores are formed that allow the content to escape. After the application of such a shear stress, the vesicles relaxed back to their spherical morphology.
As a consequence, mechanosensitive vesicles should have a lentil-shaped morphology in prevent them from undergoing apoptosis. To achieve reperfusion at affected sites, bursts of maximal doses of vasodilation, plaque-stabilizing (statins) and clot-lysing drugs are required on the site of a ruptured plaque or the embolic clot responsible for a myocardial infarction, ischemic stroke or pulmonary emboli. Systemically administered, the desired therapeutic dose cannot be achieved in such a short period of time. Systemically administered drugs in the necessary doses have crucial side effects. A conventional targeted mechanical approach requires a high-tech, in-hospital treatment by angiography or surgical intervention and requires more time until the stenosis is specifically opened to enable normal blood flow restoration. To limit complications, risk stratification protocols are studied and form the foundations, e.g., of lysis guidelines for ischemic stroke, myocardial infarction and pulmonary embolism. [44] [45] [46] Even following such a safer treatment protocol, complications are observed. 47, 48 Moreover, they limit the number of patients who
can benefit of such a treatment or limit the time window, within the treatment can be administered intravenously after symptoms begin for patients being statistically outside the given security limits. For acute ischemic stroke patients, e.g., intravenous clot lysis injection is allowed in a time-window of three to six hours after symptoms have begun. Inhospital door-to-needle time aimed to be respected is proposed to be one hour. It is important to address the impact of washout on the effectiveness of shear-stress sensitive release. One example given above 31 was tPA release at local thrombotic partial occlusion leading to improved mouse survival. Here, tPA is a fibrin-targeted molecule and its activity depends on binding fibrin. For other drugs, almost all of which are not targeted by nature, the local release will be followed by rapid washout downstream. Therefore, the presented approach, 1, 31 which overcomes the washout effect, is much more effective and of special interest. Shear stress-sensitive drug vehicles might overcome the disadvantages of protocolled, risk-stratified systemic medical treatment strategies, the endovascular device cure, or the minimal invasive or open surgical approaches.
Mechanosensitive nanocontainers can even be administrated at a pre-hospital level, depending on the disease condition. This fire and forget nano-scale drug delivery is intended for a worldwide easy, low-cost and safe application field and a potential material to influence extensively the next step of limiting burden of disease and mortality due to atherosclerosis. Today, the technology is an interesting idea, but still nothing more. A huge amount of work has to be performed, before the first patient might benefit from targeted drug delivery using mechanosensitive release from NPs or nanocontainers.
FIGURES

Figure 1
The arrows indicate the velocity profile of blood in cylindrically shaped vessels.
The shear stress in the blood vessel is the spatially dependent viscosity of blood η times the strain rate У 2 u⁄УxУy. Near the vessel wall, the strain rate is simply the blood velocity divided by the distance to the vessel wall or the tangent of the paraboloid at the wall (see upper scheme). Therefore, one uses, here, the term wall shear stress. If the vessel has a constant diameter, the wall shear stress is constant as well. At constrictions without bifurcation or bypass, however, the blood velocity and, as a consequence, the wall shear
